» » Corticosteroid Methylprednisolone Reduces Treatment Failure Among Patients With Severe Community-Acquired Pneumonia

Corticosteroid Methylprednisolone Reduces Treatment Failure Among Patients With Severe Community-Acquired Pneumonia

The use of the corticosteroid methylprednisolone, as compared to placebo, decreased treatment failure among patients with severe community-acquired pneumonia and high initial inflammatory response. Despite advances in antibiotic treatment, community-acquired pneumonia is the leading infectious cause of death in developed countries. Treatment failure is associated with excessive inflammatory response and worse outcomes in the patients. Researchers randomly ...

Read More
You have just read an article categorized health titled Corticosteroid Methylprednisolone Reduces Treatment Failure Among Patients With Severe Community-Acquired Pneumonia.
Written by: editor - Tuesday, February 17, 2015

There are currently no comments for "Corticosteroid Methylprednisolone Reduces Treatment Failure Among Patients With Severe Community-Acquired Pneumonia"

Post a Comment

Subscribe to: Post Comments (Atom)